With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.
The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.
Moderna (MRNA) announced on Wednesday that it has completed its domestic end-to-end mRNA manufacturing network with the ...
New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network ...
Moderna (MRNA) shares have been under pressure lately, slipping around 8% over the past month. Investors continue to weigh up ...
More than three-quarters of American adults didn't get a COVID shot last season, a figure that health care experts warn could ...
The Pharma Industry Is in a Bind. President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut U.S. drug prices. Nvidia stock rises after ...
Local health officials are hosting free flu vaccine clinics throughout November across eastern Idaho. The clinics by Eastern ...
Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now ...
A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...
Mixed earnings results were being mentioned on Thursday as possible catalysts behind Thursday's stock-market action. Shares of Moderna Inc. were up more than 3% after the vaccine maker reported a ...
The company posted a net loss of 51 cents a share, against Wall Street’s expectation for a loss of $2.21. Moderna has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback